Personalized Daily Doses of Imatinib by Therapeutic Drug Monitoring

Personalized daily doses of imatinib by therapeutic drug monitoring increase the rates of molecular responses in patients with chronic myeloid leukemia. Final results of the randomized OPTIM [...]